Randy Lilleston
Editor-in-Chief | @rlillestonRandy is an award-winning journalist with more than 20 years of experience in digital news, including senior-level editing positions at NPR, USA Today and CNN. He sometimes spends his nights in various Washington-area restaurants and bars, singing and playing rootsy/Americana music on several truly annoying instruments. Randy has a bachelor's degree in journalism from the University of Central Missouri, the home of the Fighting Mules.
44 articles by Randy Lilleston
-
GSK to invest $360 million in UK plants despite Brexit vote
July 28, 2016 -
FDA approves Sanofi's next-gen diabetes treatment
July 28, 2016 -
Drug industry, UK officials create Brexit task force
July 8, 2016 -
Hedge fund manager charged with insider pharma trades found dead in home
June 21, 2016 -
Former FDA official, 3 others charged in insider trading probe
June 16, 2016 -
Walgreens kills Theranos partnership, will close blood testing centers
June 13, 2016 -
Sanofi's diabetes drug hits trial targets, heads for final approval
June 13, 2016 -
Merck acquires Afferent for $500M plus milestones
June 13, 2016 -
Drugmakers plan stronger pushback on state-level price regulation
June 10, 2016 -
Martin Shkreli, the musical? It's all happening
June 9, 2016 -
Sanofi boosts takeover pressure, names Medivation board candidates
June 9, 2016 -
Valeant settles Salix drug probe for $54M
June 9, 2016 -
FDA advisory panel backs Teva opioid painkiller
June 8, 2016 -
Judge accuses Merck of 'egregious misconduct,' tosses $200M award in hep C patent suit
June 8, 2016 -
Analysis: 5 takeaways from Valeant's messy earnings report
June 7, 2016 -
High court rules GlaxoSmithKline must face RICO suits over Avandia
June 7, 2016 -
Valeant stock plunges after Q1 loss of $373M
June 7, 2016 -
Theranos says it's changing results for less than 1% of blood tests
June 6, 2016 -
Three more pharma giants subpoenaed in charity investigation
May 27, 2016 -
Sanofi goes after Medivation's board as takeover battle heats up
May 25, 2016 -
Pfizer blocks use of drugs in lethal injections, effectively closing the market
May 13, 2016 -
AMRI cuts $358M deal for Euticals
May 5, 2016 -
IMS, Quintiles to merge in $9B deal
May 3, 2016 -
Medivation rejects $9.3 billion purchase bid from Sanofi
April 29, 2016 -
AbbVie buys Stemcentrx for $5.8 billion, builds cancer drug offerings
April 28, 2016